miR-133: A Suppressor of Cardiac Remodeling?

Frontiers in Pharmacology
Ning LiQizhu Tang

Abstract

Cardiac remodeling, which is characterized by mechanical and electrical remodeling, is a significant pathophysiological process involved in almost all forms of heart diseases. MicroRNAs (miRNAs) are a group of non-coding RNAs of 20-25 nucleotides in length that primarily regulate gene expression by promoting mRNA degradation or post-transcriptional repression in a sequence-specific manner. Three miR-133 genes have been identified in the human genome, miR-133a-1, miR-133a-2, and miR-133b, which are located on chromosomes 18, 20, and 6, respectively. These miRNAs are mainly expressed in muscle tissues and appear to repress the expression of non-muscle genes. Based on accumulating evidence, miR-133 participates in the proliferation, differentiation, survival, hypertrophic growth, and electrical conduction of cardiac cells, which are essential for cardiac fibrosis, cardiac hypertrophy, and arrhythmia. Nevertheless, the roles of miR-133 in cardiac remodeling are ambiguous, and the mechanisms are also sophisticated, involving many target genes and signaling pathways, such as RhoA, MAPK, TGFβ/Smad, and PI3K/Akt. Therefore, in this review, we summarize the critical roles of miR-133 and its potential mechanisms in cardiac remodeling.

References

Jan 1, 1991·Circulation·H E Morgan, K M Baker
Mar 1, 1995·Journal of Molecular and Cellular Cardiology·A M Gerdes, J M Capasso
Jan 1, 1993·Advances in Experimental Medicine and Biology·G F MitchellM A Pfeffer
Feb 3, 2000·Proceedings of the National Academy of Sciences of the United States of America·T TaigenJ D Molkentin
Jul 13, 2000·Cell·E N Olson, R S Williams
Mar 10, 2001·Nature·L Chang, M Karin
Aug 21, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S WenzelK D Schlüter
Sep 13, 2001·Molecular Biology of the Cell·B HinzC Chaponnier
Aug 3, 2002·Hypertension·Yuri Akiyama-UchidaKatsusuke Yano
Aug 30, 2002·Blood·Chern-En ChiangPhilip Yu-An Ding
Oct 3, 2002·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Hiroyuki TakanoIssei Komuro
Mar 18, 2003·The Journal of Clinical Investigation·Shaosong ZhangAnthony J Muslin
May 28, 2003·Biochemical and Biophysical Research Communications·Toshio NagaiIssei Komuro
Oct 24, 2003·The Journal of Biological Chemistry·Kenneth L FriedrichElizabeth Vierling
May 8, 2004·Trends in Biochemical Sciences·Peter ten Dijke, Caroline S Hill
Jan 7, 2006·Circulation Research·Johannes Backs, Eric N Olson
Aug 29, 2006·Nature Reviews. Molecular Cell Biology·Joerg Heineke, Jeffery D Molkentin
Oct 25, 2006·Nature Reviews. Cancer·George A Calin, Carlo M Croce
Jan 20, 2007·Circulation Research·Danish SayedMaha Abdellatif
May 1, 2007·Nature Medicine·Alessandra CarèGianluigi Condorelli
Jun 15, 2007·Circulation·Darwin JeyarajDavid S Rosenbaum
Aug 31, 2007·American Journal of Physiology. Cell Physiology·Lijun LiuAmir Askari
Jan 9, 2008·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Samir SabaBarry London
Feb 5, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Haiying YuOliver Eickelberg
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jens FielitzEric N Olson
Mar 29, 2008·Cell Stem Cell·Kathryn N IveyDeepak Srivastava
Jul 16, 2008·European Heart Journal·Bobby JohnPrashanthan Sanders
Aug 6, 2008·The Journal of Cell Biology·Jong-Sun KangRobert S Krauss
Oct 17, 2008·PloS One·Ming LuQinghua Cui
May 8, 2009·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Swapna KamireddySamir Saba

❮ Previous
Next ❯

Citations

Jun 27, 2019·Journal of Cellular and Molecular Medicine·Enrica PinchiVittorio Fineschi
Jul 17, 2019·Cold Spring Harbor Perspectives in Biology·Guillaume GilbertH Llewelyn Roderick
Mar 15, 2020·Heart Failure Reviews·Bianca Olivia Cojan-MinzatLucia Agoston-Coldea
May 13, 2020·Journal of Cellular and Molecular Medicine·Zuzana KmecovaJan Klimas
Dec 12, 2018·Molecular Medicine Reports·Youbang XieYuhai Gu
Apr 20, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Huiyang ChenAiming Wu
Dec 4, 2019·The American Journal of Chinese Medicine·Yonghui YuChenglong Wang
Dec 16, 2019·Heart Failure Reviews·Abdelrahman Yousry Afify
Feb 7, 2020·International Journal of Molecular Sciences·Yi-Chou HouKuo-Cheng Lu
Oct 30, 2020·International Journal of Molecular Sciences·Leyre López-MunetaXonia Carvajal-Vergara
Feb 7, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Ning LiQing Geng
Jan 8, 2021·Frontiers in Cell and Developmental Biology·Jacopo Di GregorioVincenzo Flati
Feb 27, 2021·Interface Focus·D E PhelanE P Cummins
Apr 4, 2021·International Journal of Molecular Sciences·Sean T RyanJiao Jiao Li
Jun 3, 2021·International Journal of Molecular Sciences·Mihir Parikh, Grant N Pierce
Aug 24, 2021·The Nucleus : an International Journal of Cytology and Allied Topics·Gaurab Aditya DharRonita Nag Chaudhuri
Feb 3, 2022·Molecular Biotechnology·Wenhui WangXinming Li

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
nuclear translocation
transfection

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.